Warning! GuruFocus has detected 2 Severe warning signs with FMTX. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for FMTX (Forma Therapeutics Holdings Inc) from 2020 to May 05 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Forma Therapeutics stock (FMTX) PE ratio as of May 05 2021 is 0. More Details
Forma Therapeutics PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Forma Therapeutics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Traded in other countries
500 Arsenal Street, Suite 100, Watertown, MA, USA, 02472
Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are FT-4202, FT-7051, FT-8225, and others.